Hangzhou Minsheng Healthcare's (SHE:301507) chairman, Zhu Fujian, proposed to repurchase company shares to be used as stock incentives, according to a Shenzhen Stock Exchange disclosure on Friday.
About 0.36% to 0.41% of the medical products manufacturer's shares, equivalent to between 1.3 million and 1.5 million shares, will be bought back within 12 months after the approval of the board of directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments